News Conference News VIVA 2019 IN.PACT Global Registry Shows Continued Safety, Efficacy at 4 Years for Paclitaxel DCB L.A. McKeown November 05, 2019
News Industry News Two-year data shows trend towards lower target vessel failure with Indian stent Supraflex vs. Xience stent from Abbott October 09, 2019
Presentation TCT 2019 MAGSTEMI: A Randomized Trial of a Magnesium-Based Sirolimus-Eluting Resorbable Scaffold vs. Metallic DES in Patients With STEMI Presenter: Manel Sabate September 27, 2019
Presentation TCT 2019 12-Month Clinical Outcomes of Sirolimus-Eluting Bioresorbable Peripheral Scaffold System in Arteries Below the Knee Presenter: Sahil Parikh September 27, 2019
Presentation TCT 2019 1-Year Clinical Results of Real-Life Registry of Angiolite® Cobalt-Chromium Sirolimus-Eluting Stent (Rango Registry) Presenter: Armando Pérez de Prado September 27, 2019
Presentation TCT 2019 MODEL U-SES: A Single-Arm Study of 3-Month DAPT in Patients Treated With a Bioabsorbable Polymer-Based Sirolimus-Eluting Stent Presenter: Ken Kozuma September 26, 2019
Presentation TCT 2019 Current DCBs: Challenges of Paclitaxel and the Downsides of Coatings Presenter: Robert Byrne September 26, 2019
Presentation TCT 2019 Virtue® SEB: Promising Data for Innovative LIMUS Delivery Presenter: Juan Granada September 26, 2019
Presentation TCT 2019 TCT 46: FANTOM II trial: Safety & Performance Study of the Fantom Sirolimus-Eluting Bioresorbable Coronary Scaffold – First Report on Initial 48 Month Outcomes Presenter: Alexandre Abizaid September 25, 2019
Presentation TCT 2019 TCT 43: A Prospective Randomized Multicenter Study to Assess the Safety and Effectiveness of the Orsiro Sirolimus Eluting Stent in the Treatment of Subjects with up to two de novo Coronary Artery Lesions – BIOFLOW IV: 4 Years Clinical Results Presenter: Bernhard Witzenbichler September 25, 2019
Presentation TCT 2019 TCT 41: A prospective multicentre randomized all-comers trial to assess the safety and effectiveness of the ultra-thin-strut sirolimus-eluting coronary stent Supraflex: 2-year results of the TALENT trial Presenter: Azfar Zaman September 25, 2019
News Conference News ESC 2019 BIOSTEMI: Ultrathin-Strut Orsiro Superior to Xience for 1-Year TLF After Primary PCI Caitlin E. Cox September 10, 2019
News Industry News SMT Announces CE* Mark for the Most Deliverable Stent Supraflex Cruz July 11, 2019
News Conference News EuroPCR 2019 Daring to Dream: New BRS Data Hint at Low MACE Rates at 2 and 3 Years Michael O'Riordan May 27, 2019
News Industry News Latest generation DES: ANGIOLITE trial 24-month outcomes revealed at EuroPCR 2019 the non-inferiority of angiolite vs the gold standard EES May 23, 2019
News Conference News EuroPCR 2019 Firehawk Stent Still Holds Up Well to Xience at 2 Years: TARGET All Comers Caitlin E. Cox May 23, 2019
News Conference News EuroPCR 2019 Ultrathin Struts Show Strength in Small Vessels: BIO-RESORT at 3 Years Caitlin E. Cox May 21, 2019
Podcast TCTMD Talking Points RESET: Seven-Year Follow-up From a Randomized Trial of Sirolimus-Eluting vs Everolimus-Eluting Stents in Patients With Coronary Artery Disease May 01, 2019
Presentation CIT 2019 A Randomized Trial Comparing a Novel Sirolimus-Eluting Bioresorbable Scaffold with Everolimus-Eluting Metallic Stent in Patients with Coronary Artery Disease: Three-Year Results of NeoVas RCT Presenter: Yaling Han March 28, 2019